111In-pentetreotide scintigraphy should be the first test in the assessment of gastroenteropancreatic (GEP) tumours

C Marí, Bernà Ll, A Flotats, JC Martín, M Estorch, A Catafau, I Carrió

Research output: Contribution to journal › Article › Research

Cite this

@article{aa438c233ca344b2b507d69cd09f54dd,

title = "111In-pentetreotide scintigraphy should be the first test in the assessment of gastroenteropancreatic (GEP) tumours",

author = "C Mar{\'i} and Bern{\`a} Ll and A Flotats and JC Mart{\'i}n and M Estorch and A Catafau and I Carri{\'o}",

year = "1998",

month = jan,

day = "1",

language = "English",

volume = "25",

pages = "1116--",

}